Back
Crinetics Pharmaceuticals Vs. Zevra Therapeutics Industry Stock Comparison
Sell
40
CRNX
Crinetics Pharmaceuticals
Last Price:
53.31
Seasonality Move:
3%
Buy
52
ZVRA
Zevra Therapeutics
Last Price:
8.06
Seasonality Move:
-17.07%
Sell
40
Crinetics Pharmaceuticals (CRNX)
is a Sell
Is Crinetics Pharmaceuticals a Buy, Sell or Hold?
- The current Crinetics Pharmaceuticals [CRNX] share price is $53.15. The Score for CRNX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Zevra Therapeutics (ZVRA)
is a Buy
Is Zevra Therapeutics a Buy, Sell or Hold?
- The current Zevra Therapeutics [ZVRA] share price is $8.06. The Score for ZVRA is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- ZVRA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals's stock price today?
-
The Crinetics Pharmaceuticals share price today is $53.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing selling pressure, which indicates risk of future bearish movement.
ZVRA Stock Price Chart
What is Zevra Therapeutics's stock price today?
-
The Zevra Therapeutics share price today is $8.06
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing slight selling pressure.
CRNX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.38 | Buy |
Relative Strength Index (14 RSI): | 53.16 | Buy |
Chaikin Money Flow: | -745209 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.51 - 53.91) | Buy |
Bollinger Bands (100): | (46.15 - 53.13) | Buy |
ZVRA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.28 | Buy |
Relative Strength Index (14 RSI): | 64.18 | Buy |
Chaikin Money Flow: | -1240392 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.17 - 7.73) | Buy |
Bollinger Bands (100): | (4.65 - 7.11) | Buy |
CRNX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 52.82 | Buy |
20-day SMA: | 52.61 | Buy |
50-day SMA: | 52.41 | Buy |
200-day SMA: | 44.59 | Buy |
8-day EMA: | 52.94 | Buy |
20-day EMA: | 52.54 | Buy |
50-day EMA: | 51.54 | Buy |
200-day EMA: | 44.39 | Buy |
ZVRA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.76 | Buy |
20-day SMA: | 7.47 | Buy |
50-day SMA: | 7.01 | Buy |
200-day SMA: | 5.77 | Buy |
8-day EMA: | 7.78 | Buy |
20-day EMA: | 7.52 | Buy |
50-day EMA: | 6.95 | Buy |
200-day EMA: | 5.9 | Buy |
Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.16 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.25 per share.
Zevra Therapeutics Earnings Growth & ZVRA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.29 per share, a decrease this year of $0.32 per share, and an increase next year of $0.99 per share.
Crinetics Pharmaceuticals Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Zevra Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |